8th September 2009

                       REGEN THERAPEUTICS PLC
              ("ReGen" or the "Company"; Ticker: (RGT))


TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying    ReGen Therapeutics Plc
issuer of existing shares to which voting
rights are attached (ii):


2. Reason for the notification:                An event changing the
                                               breakdown of voting
                                               rights


3. Full name of person(s) subject to the       Tigran Kalaydjian
notification obligation (iii):


4. Full name of shareholder(s) (if difference  Unokal Ltd, Clariant
from 3):                                       Foundation


5. Date of the transaction and date on which   8th September 2009
the threshold is crossed or reached (v):


6. Date on which issuer notified:              8th September 2009


7.  Threshold(s) that is/are crossed or        3% to 2%
reached:

8.  Notified details

A: Voting rights attached to shares

Class/type of share if possible using the ISIN GB0004468319
Code

Situation Previous to the triggering
transaction (vi) -
Number of Shares                               1,000,000
Number of Voting Rights (viii)                 1,000,000

Resulting situation after the triggering
transaction (viii) -
Number of Shares                               1,000,000
Number of Voting Rights - Direct (x)           N/A
Number of Voting Rights - Indirect (xi)        1,000,000
% of voting rights - Direct                    N/A
% of voting rights - Indirect                  2.92

B: Financial Instruments

Resulting situation after the triggering
transaction (xii)

Type of financial instrument                   N/A
Expiration date (xiii)                         N/A
Exercise/Conversion Period/Date (xiv)          N/A
Number of voting rights that may be acquired   N/A
if the instrument is exercised/converted
% of voting rights                             N/A


C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments

Resulting situation after the triggering
transaction

Type of financial instrument                   N/A
Exercise Price                                 N/A
Experation Date                                N/A
Number of voting rights                        N/A
Instrument refers to
% of voting rights                             N/A

Total (A+B+C)


Number of voting rights                        1,000,000
% of voting rights                             2.92


9.  Chain of controlled undertakings through   Unokal Ltd, Clariant
which the voting rights and/or the financial   Foundation
instruments are effectively held, if
applicable (xv):

Proxy Voting:

10. Name of the proxy holder:                  N/A
11. Number of voting rights proxy holder will  N/A
cease to hold:
12. Date on which proxy holder will cease to   N/A
hold voting rights:
13. Additional information:                    N/A
14. Contact name:
15. Contact telephone number:






For further information:

For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920

Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.